Oncological management of pancreatic cancer in advanced stages

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Historically, 5-fluorouracil (5-FU)-based chemotherapy has been the most widely studied chemotherapeutic agent for all stages of pancreatic cancer. Despite more recent attempts to modify the delivery of 5-FU, response rates have remained unchanged in the 10-20% range with median survival of 4-5 months for patients with stage IV disease [1-5].

Original languageEnglish (US)
Title of host publicationDiseases of the Pancreas
Subtitle of host publicationCurrent Surgical Therapy
PublisherSpringer Berlin Heidelberg
Pages549-557
Number of pages9
ISBN (Print)9783540286554
DOIs
StatePublished - Dec 1 2008

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Oncological management of pancreatic cancer in advanced stages'. Together they form a unique fingerprint.

Cite this